Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Aegenta Vr

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1
Completed1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07838181Not ApplicableRecruiting

Virtual Reality Aniseikonia and Metamorphopsia Testing

NCT04089033Completed

Retinal Displacement After Pneumatic Versus Vitrectomy for Retinal Detachment (ALIGN)

NCT03832335UnknownPrimary

A New Measurement of Anseikonia Tolerance

Showing all 3 trials

Research Network

Common Treatments

  • Aegenta Vr1
  • Pneumatic Retinopexy1
  • Pars Plana Vitrectomy1
  • Measurement Of Aniseikonia Tolerance1

Active Sponsors

  • Glostrup University Hospital, Copenhagen1
  • NYU Langone Health1
  • Unity Health Toronto1

Top Investigators

Related Conditions

  • Metamorphopsia2
  • Anisometropia And Aniseikonia1
  • Retinal Detachment1

Activity Timeline